We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+2.75%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$27.5B
AUM Growth
+$4.26B
Cap. Flow
+$26B
Cap. Flow %
94.62%
Top 10 Hldgs %
8.07%
Holding
3,226
New
745
Increased
868
Reduced
662
Closed
894

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$151M
2
JNJ icon
Johnson & Johnson
JNJ
+$149M
3
COP icon
ConocoPhillips
COP
+$142M
4
DHR icon
Danaher
DHR
+$112M
5
SPGI icon
S&P Global
SPGI
+$106M

Sector Composition

Rank Sector Weight
1 Technology 21.09%
2 Consumer Discretionary 14.55%
3 Financials 12.04%
4 Healthcare 11.32%
5 Industrials 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSBK icon
3026
Timberland Bancorp
TSBK
$343M
-15,708
Closed -$424K
TTI icon
3027
TETRA Technologies
TTI
$1.23B
-167,219
Closed -$443K
TTT icon
3028
ProShares UltraPro Short 20+ Year Treasury
TTT
$18.7M
-6
Closed -$366
TUSK icon
3029
Mammoth Energy Services
TUSK
$132M
-38,008
Closed -$160K
TWLO icon
3030
Twilio
TWLO
$29.1B
-36,829
Closed -$2.45M
TWM icon
3031
ProShares UltraShort Russell2000
TWM
$43.2M
-29
Closed -$2.22K
TWST icon
3032
Twist Bioscience
TWST
$5.62B
-106,993
Closed -$1.61M
TYL icon
3033
Tyler Technologies
TYL
$12.2B
-18,194
Closed -$6.45M
U icon
3034
Unity
U
$12.5B
-134,221
Closed -$4.35M
UCO icon
3035
ProShares Ultra Bloomberg Crude Oil
UCO
$443M
-21
Closed -$556
UEC icon
3036
Uranium Energy
UEC
$4.71B
-417,056
Closed -$1.2M
UFPT icon
3037
UFP Technologies
UFPT
$1.84B
-8,908
Closed -$1.16M
UGP icon
3038
Ultrapar
UGP
$6.87B
-22,473
Closed -$61.4K
UHS icon
3039
Universal Health Services
UHS
$9.43B
-22,760
Closed -$2.89M
ULCC icon
3040
Frontier Group Holdings
ULCC
$1.34B
-250,790
Closed -$2.47M
UMBF icon
3041
UMB Financial
UMBF
$10.7B
-67,805
Closed -$3.91M
UNIT
3042
Uniti Group
UNIT
$2.63B
-674,637
Closed -$2.39M
UP icon
3043
Wheels Up
UP
$220M
-150
Closed -$19K
UPRO icon
3044
ProShares UltraPro S&P 500
UPRO
$5.1B
-8,893
Closed -$343K
URGN icon
3045
UroGen Pharma
URGN
$2B
-46,213
Closed -$427K
URNM icon
3046
Sprott Uranium Miners ETF
URNM
$1.78B
-12,254
Closed -$384K
URTY icon
3047
ProShares UltraPro Russell2000
URTY
$323M
-884
Closed -$33.5K
USB icon
3048
US Bancorp
USB
$99.6B
-460,463
Closed -$16.6M
UVSP icon
3049
Univest Financial
UVSP
$1.23B
-23,782
Closed -$565K
UVXY icon
3050
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$249M
-5
Closed -$6.21K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2023 Portfolio in Review

As of Q2 2023, Qube Research & Technologies (QRT) held 3,226 positions worth $27.5B, up 18% from $23.2B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Qube Research & Technologies (QRT) deployed $26B of net new capital in Q2 2023, opening 745 new positions and adding to 868 existing holdings. Its largest new stake was Microsoft: 704,526 shares worth $240M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Cigna, an estimated $151M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2023 buy was Microsoft: 704,526 shares worth $240M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2023, an estimated $192M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2023 reduction was Cigna, cutting an estimated $151M.
  • Qube Research & Technologies (QRT) fully exited ConocoPhillips in Q2 2023, selling an estimated $142M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 8.1% of its $27.5B portfolio in Q2 2023.
  • Qube Research & Technologies (QRT) opened 745 new positions and closed 894 in Q2 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 18% quarter-over-quarter to $27.5B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.